ABSTRACT
Recent advances in mass spectrometry (MS) techniques have radically changed the analysis of biomolecules. MS has become the analytical method of choice for discovery and characterization of molecules with therapeutic value. Technological breakthroughs in the discovery area are now increasingly applied in the process development field and have recently entered the production process in manufacturing and quality control (QC) areas. In this presentation, after a review of the current state of the art, we would like to demonstrate how MS methods are influencing the development and manufacturing of therapeutic molecules.
